We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Brain's Connectivity Processes Investigated by Virus "Explorers”

By LabMedica International staff writers
Posted on 28 Jul 2010
Researchers are devising a new technique for studying brain connectivity.

Success in figuring out the wiring diagram of the brain could transform the field of neuroscience, with implications for learning more about disorders varying from depression and schizophrenia to Parkinson's and Alzheimer's disease. More...


Dr. Lynn Enquist, a professor in Princeton University's (Princeton, NJ, USA) department of molecular biology and in the Princeton Neuroscience Institute, is leading the project to utilize genetically engineered viruses as ‘explorers' that move throughout the nervous system, following the connections between neurons and reporting on their activity along the way. "Over the years, the understanding of how cells in the brain are connected has been a major problem,” stated Dr. Enquist, a professor of molecular biology. "How can this blob of tissue do everything [it does]? We're missing a lot of information about how the brain works.”

The U.S. National Institutes of Health (NIH; Bethesda, MD, USA)-funded project hinges on the creation and use of a genetically modified virus that causes neurons to generate colorful fluorescent proteins. As the virus spreads, it leaves a colorful path through the brain in its wake. Some of the engineered viruses are designed to make the neurons glow brightly when they are active. "These DNA-based technologies allow us to put little labels on neurons that tell who they are connected to,” said team member Dr. Samuel Wang, an associate professor in the department of molecular biology and in the Princeton Neuroscience Institute.

Chemicals exist that can be used to trace brain connectivity, including specific molecules from the horseradish plant and the cholera toxin, but they become increasingly dilute as they spread throughout the brain. Other chemicals can alter color or brightness when a neuron is active, but they label all cells indiscriminately, leading to a foggy image. Because viruses replicate, they are self-amplifying and do not become less concentrated as they move away from their entry point into the brain, making them a potential tool for researchers seeking to probe the elusive areas of the brain.

Viruses also can target subsets of neurons, making them glow--and therefore stand out--in sharp relief. Dr. Enquist and his collaborators are now conducting laboratory research in test tubes and mice as they try to increase essential knowledge about neural connectivity, which has significant implications for understanding the human brain.

Related Links:
Princeton University



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.